{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T14:52:46Z","timestamp":1771512766039,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.jaad.2015.07.010","type":"journal-article","created":{"date-parts":[[2015,8,29]],"date-time":"2015-08-29T12:05:13Z","timestamp":1440849913000},"page":"821-828","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Generalized benign cutaneous reaction to cytarabine"],"prefix":"10.1016","volume":"73","author":[{"given":"Beth S.","family":"Ruben","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wesley Y.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam V.","family":"Truong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin C.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindy P.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jaad.2015.07.010_bib1","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/1097-0142(19851001)56:7<1493::AID-CNCR2820560702>3.0.CO;2-M","article-title":"High-dose cytosine arabinoside in previously treated patients with poor-prognosis non-Hodgkin's lymphoma","volume":"56","author":"Adelstein","year":"1985","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.jaad.2015.07.010_bib2","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0025-7125(16)31122-1","article-title":"Adult acute nonlymphocytic leukemia","volume":"68","author":"Cassileth","year":"1984","journal-title":"Med Clin North Am"},{"issue":"2","key":"10.1016\/j.jaad.2015.07.010_bib3","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/BF00254596","article-title":"High-dose cytosine arabinoside: response to therapy in acute leukemia and non-Hodgkin's lymphoma","volume":"12","author":"Rohatiner","year":"1984","journal-title":"Cancer Chemother Pharmacol"},{"issue":"5","key":"10.1016\/j.jaad.2015.07.010_bib4","first-page":"253","article-title":"High dose cytarabine: a review","volume":"2","author":"Bolwell","year":"1988","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.jaad.2015.07.010_bib5","first-page":"1191","article-title":"Cutaneous toxicity associated with high-dose cytosine arabinoside","volume":"19","author":"Richards","year":"1992","journal-title":"Oncol Nurs Forum"},{"issue":"2","key":"10.1016\/j.jaad.2015.07.010_bib6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/sj.leu.2400572","article-title":"High-dose cytosine\u00a0arabinoside and etoposide: an effective regimen without anthracyclines for refractory childhood acute non-lymphocytic leukemia","volume":"11","author":"Whitlock","year":"1997","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.jaad.2015.07.010_bib7","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1046\/j.1468-3083.2002.00395.x","article-title":"High-dose cytosine arabinoside-induced cutaneous reactions","volume":"16","author":"Cetkovska","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"9","key":"10.1016\/j.jaad.2015.07.010_bib8","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1001\/archderm.1986.01660210073021","article-title":"Chemotherapy-induced acral erythema in patients receiving bone marrow transplantation","volume":"122","author":"Crider","year":"1986","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2015.07.010_bib9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0190-9622(99)70488-3","article-title":"Mucocutaneous reactions to chemotherapy","volume":"40","author":"Susser","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2015.07.010_bib10","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/archderm.1985.01660100020006","article-title":"Cytarabine-induced palmar-plantar erythema","volume":"121","author":"Walker","year":"1985","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2015.07.010_bib11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archderm.1993.01680220055012","article-title":"Bullous variant of chemotherapy-induced acral erythema","volume":"129","author":"Waltzer","year":"1993","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2015.07.010_bib12","first-page":"501","article-title":"Dermatologic toxicity of chemotherapy","volume":"19","author":"DeSpain","year":"1992","journal-title":"Semin Oncol"},{"issue":"1","key":"10.1016\/j.jaad.2015.07.010_bib13","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1001\/archderm.1985.01660010106031","article-title":"Distinctive acral erythema occurring during therapy for severe\u00a0myelogenous leukemia","volume":"121","author":"Levine","year":"1985","journal-title":"Arch Dermatol"},{"issue":"6 Pt 1","key":"10.1016\/j.jaad.2015.07.010_bib14","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/0190-9622(90)70342-F","article-title":"Neutrophilic eccrine hidradenitis in two neutropenic patients","volume":"23","author":"Allegue","year":"1990","journal-title":"J Am Acad Dermatol"},{"issue":"5 Pt 1","key":"10.1016\/j.jaad.2015.07.010_bib15","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0190-9622(93)70090-G","article-title":"Neutrophilic eccrine hidradenitis","volume":"28","author":"Thorisdottir","year":"1993","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2015.07.010_bib16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4065\/73.3.239","article-title":"Cytosine arabinoside-induced vasculitis","volume":"73","author":"Ahmed","year":"1998","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.jaad.2015.07.010_bib17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1001\/archderm.1990.01670250079013","article-title":"Eccrine squamous syringometaplasia. A cutaneous sweat gland reaction in the histologic spectrum of \u2018chemotherapy-associated eccrine hidradenitis\u2019 and \u2018neutrophilic eccrine hidradenitis\u2019","volume":"126","author":"Hurt","year":"1990","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2015.07.010_bib18","first-page":"694","article-title":"Treatment of poor risk acute leukemia with sequential high-dose ARA-C and asparaginase","volume":"63","author":"Capizzi","year":"1984","journal-title":"Blood"},{"issue":"2 Suppl 3","key":"10.1016\/j.jaad.2015.07.010_bib19","first-page":"105","article-title":"Sequential high-dose ara-C and asparaginase in the therapy of previously treated and untreated patients with acute leukemia","volume":"12","author":"Capizzi","year":"1985","journal-title":"Semin Oncol"},{"issue":"2","key":"10.1016\/j.jaad.2015.07.010_bib20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1182\/blood.V62.2.361.361","article-title":"High-dose cytosine arabinoside therapy for refractory leukemia","volume":"62","author":"Herzig","year":"1983","journal-title":"Blood"},{"issue":"2 Suppl 3","key":"10.1016\/j.jaad.2015.07.010_bib21","first-page":"150","article-title":"Continuous infusion of high-dose cytosine arabinoside for treatment of childhood acute leukemia and non-Hodgkin's lymphoma in relapse","volume":"12","author":"Jones","year":"1985","journal-title":"Semin Oncol"},{"issue":"Suppl 2","key":"10.1016\/j.jaad.2015.07.010_bib22","first-page":"66","article-title":"Intensive post-remission therapy with Ara-C in adults with acute myeloid leukemia: initial results of a CALGB phase III trial. The Cancer and Leukemia Group B","volume":"6","author":"Mayer","year":"1992","journal-title":"Leukemia"},{"issue":"2 Suppl 1","key":"10.1016\/j.jaad.2015.07.010_bib23","first-page":"12","article-title":"High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an update","volume":"14","author":"Wolff","year":"1987","journal-title":"Semin Oncol"},{"issue":"6","key":"10.1016\/j.jaad.2015.07.010_bib24","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1182\/blood.V65.6.1407.bloodjournal6561407","article-title":"High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: a pilot study","volume":"65","author":"Wolff","year":"1985","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.jaad.2015.07.010_bib25","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1034\/j.1600-0560.2002.291002.x","article-title":"Keratinocyte dysplasia: an usual finding after transplantation or chemotherapy","volume":"29","author":"Casta\u00f1o","year":"2002","journal-title":"J Cutan Pathol"},{"issue":"10","key":"10.1016\/j.jaad.2015.07.010_bib26","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1034\/j.1600-0560.2002.291001.x","article-title":"Chemotherapy and keratinocytes","volume":"29","author":"Henry","year":"2002","journal-title":"J Cutan Pathol"},{"issue":"3","key":"10.1016\/j.jaad.2015.07.010_bib27","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0190-9622(91)70073-B","article-title":"Chemotherapy-induced acral erythema","volume":"24","author":"Baack","year":"1991","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2015.07.010_bib28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/j.seminoncol.2005.11.006","article-title":"Vascular toxicity of antineoplastic agents","volume":"33","author":"Shahab","year":"2006","journal-title":"Semin Oncol"},{"issue":"1","key":"10.1016\/j.jaad.2015.07.010_bib29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1089\/dst.2012.0004","article-title":"Enhancing thermal exchange in humans and practical applications","volume":"1","author":"Heller","year":"2012","journal-title":"Disrupt Sci Technol"},{"issue":"10","key":"10.1016\/j.jaad.2015.07.010_bib30","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1097\/00019501-199310000-00014","article-title":"The in-vitro effect of antineoplastic agents on proliferative activity and cytoskeletal components of plaque-derived smooth-muscle cells from human coronary arteries","volume":"4","author":"Voisard","year":"1993","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.jaad.2015.07.010_bib31","series-title":"Dermatology","author":"Bolognia","year":"2012"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962215018812?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962215018812?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:36:40Z","timestamp":1759271800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962215018812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0190962215018812"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2015.07.010","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generalized benign cutaneous reaction to cytarabine","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2015.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}